Hospitals; emergency treatment for substance use-related emergencies. (HB2300)

Introduced By

Del. Karrie Delaney (D-Centreville) with support from co-patron Sen. John Bell (D-Chantilly)


Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law


State Board of Health; hospitals; emergency treatment for substance use-related emergencies; services. Requires each hospital with an emergency department that is currently regulated by the State Board of Health (the Board) to establish a protocol for treatment and discharge of individuals experiencing a substance use-related emergency, which shall include provisions for (i) appropriate screening and assessment of individuals experiencing substance use-related emergencies and (ii) recommendations for follow-up care, which may include dispensing of naloxone or other opioid antagonist used for overdose reversal, issuance of a prescription for naloxone, and information about accessing naloxone at a community pharmacy or organization that dispenses naloxone or other opioid antagonist to persons without a prescription. Such protocols may also include referrals to peer recovery specialists and community-based providers of behavioral health services or providers of pharmacotherapy for the treatment of drug or alcohol dependence or mental health diagnoses. The bill also directs the Department of Health, together with the Department of Health Professions, to convene a work group to develop recommendations for best practices for the treatment and discharging of patients in emergency departments experiencing opioid-related emergencies, including overdose, which shall include recommendations for best practices related to (a) performing substance use assessments and screenings for patients experiencing opioid-related overdose and other high-risk patients; (b) prescribing and dispensing naloxone or other opioid antagonists used for overdose reversal; (c) connecting patients treated for opioid-related emergencies, including overdose, and their families with community substance abuse resources, including existing harm reduction programs and other treatment providers; and (d) identifying barriers to and developing solutions to increase the availability and dispensing of naloxone or other opioid antagonist used for overdose reversal at hospitals and community pharmacies and by other community organizations. The bill also provides that hospitals in the Commonwealth may enter into agreements with the Department of Health for the provision to uninsured patients of naloxone or other opioid antagonist used for overdose reversal. Read the Bill »


02/04/2021: In Committee


01/18/2021Presented and ordered printed 21103156D
01/18/2021Referred to Committee on Health, Welfare and Institutions
01/23/2021Assigned HWI sub: Health
01/26/2021House subcommittee amendments and substitutes offered
01/26/2021Subcommittee recommends reporting with amendments (7-Y 0-N)
01/28/2021Reported from Health, Welfare and Institutions with substitute (21-Y 0-N) (see vote tally)
01/28/2021Committee substitute printed 21103718D-H1
02/01/2021Impact statement from DPB (HB2300H1)
02/01/2021Read first time
02/02/2021Read second time
02/02/2021Committee substitute agreed to 21103718D-H1
02/02/2021Engrossed by House - committee substitute HB2300H1
02/03/2021Read third time and passed House BLOCK VOTE (98-Y 0-N 1-A)
02/03/2021VOTE: Block Vote Passage (98-Y 0-N 1-A) (see vote tally)
02/03/2021Reconsideration of passage agreed to by House
02/03/2021Passed House BLOCK VOTE (99-Y 0-N)
02/03/2021VOTE: Block Vote Passage #2 (99-Y 0-N) (see vote tally)
02/04/2021Constitutional reading dispensed
02/04/2021Referred to Committee on Education and Health
02/05/2021Continued to 2021 Sp. Sess. 1 in Education and Health (15-Y 0-N) (see vote tally)